GNPX Stock Price and Chart — NASDAQ:GNPX — TradingView (2024)

GNPX chart

Full chart

Upcoming earnings

Next report date

Report period

EPS estimate

Revenue estimate

Key stats

Market capitalization

‪4.13 M‬USD

Dividend yield (indicated)

Price to earnings Ratio (TTM)

Basic EPS (TTM)

−19.18USD

Net income (FY)

‪−30.86 M‬USD

Revenue (FY)

Shares float

‪2.06 M‬

Beta (1Y)

3.58

About Genprex, Inc.

Sector

Health Technology

CEO

Ryan M. Confer

Headquarters

Austin

Employees (FY)

26

Founded

2009

FIGI

BBG00F7T0157

Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.

Ideas

GNPXNice pop impulse recently. Most resiatnce I see is around 4$. As of now holding some solid support based off my favorite indicators. If w can pop 2.88 and hold should see another run. Don’t think it’s over yet, cpuldBe just the beginning. 1 hour potential double bottom. Stops below 2.50$

Long

by Erictaylor

$GNPX Target PTs 7 and higherGenprex Receives U.S. FDA Fast Track Designation for REQORSA™️ Immunogene Therapy in Combination With Keytruda®️ for the Treatment of Non-Small Cell Lung CancerSecond FDA Fast Track Designation Further Validates the Potential of REQORSAAUSTIN, Texas, January 03, 2022--(BUSINESS WIRE)--Genprex, I

Long

by BADQOMOCAWGOWLD

Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ ImGNPX: Genprex, Inc.2022-01-03 08:00:00Genprex Receives U.S. FDA Fast Track Designation for REQORSA™ Immunogene Therapy in Combination With Keytruda® for the Treatment of Non-Small Cell Lung Cancer

Long

by RocketTickers

11

GNPXMID-TERM: Trying to hold a support with potential classic bullish divergence on the 4hr and potential hidden bullish divergence on the daily, if it pivots here. (not financial advice)

Long

by Champion-Vibe

GNPX: potential gap up tomorrow!huge amazing wedge!! this is the third time that price has made it to $4.25. GNPX has been rejected at this price twice before. Third time is winner yes?

Long

by ZombieStar

55

GNPXA deal I'm going to make opinions on?

Long

by DavidShagabaev

$GNPXMomentum to continue

Long

by tradingbulls2

Out of jail cardNo volume, no momentum yet

Long

by pantheo

22

GNPX *ON HIGH ALERT MONDAY PRE MARKET*Same for this one it could gap up over resistance, or actually gap down just have to wait and see. Set alerts. Add to watchlist.

by DigitalData

22

Genprex around 100% profit next weeksAbout Genprex Inc Genprex, Inc. operates as a biotechnology company. The Company discovers and develops immunogene therapies for cancer treatment, as well as provides clinical research, gene therapies, consulting, and other related medical services. Genprex serves customers in the United States.

Long

by tdiallo
See all ideas
Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

GNPX Stock Price and Chart — NASDAQ:GNPX — TradingView (21)

Interactive Brokers

Featured

4.4Very Good

Learn more

GNPX Stock Price and Chart — NASDAQ:GNPX — TradingView (22)

TradeStation

4.5Great

Learn more

See all brokers

The current price of

GNPX

is

2.00

USD

— it has increased by

1.52

% in the past 24 hours. Watch

Genprex, Inc.

stock price performance more closely on the chart.

Depending on the exchange, the stock ticker may vary. For instance, on

NASDAQ

exchange

Genprex, Inc.

stocks are traded under the ticker

GNPX

.

GNPX

stock has fallen by

1.96

% compared to the previous week, the month change is a

3.94

% fall, over the last year

Genprex, Inc.

has showed a

93.98

% decrease.

We've gathered analysts' opinions on

Genprex, Inc.

future price: according to them,

GNPX

price has a max estimate of

10.00

USD

and a min estimate of

10.00

USD

. Watch

GNPX chart

and read a more detailed

Genprex, Inc. stock forecast

: see what analysts think of

Genprex, Inc.

and suggest that you do with its stocks.

GNPX

reached its all-time high on

Apr 30, 2018

with the price of

778.00

USD

, and its all-time low was

1.77

USD

and was reached on

Jul 10, 2024

. View more price dynamics on

GNPX chart

.
See other stocks reaching their highest and lowest prices.

GNPX

stock is

8.67

% volatile and has beta coefficient of

3.58

. Track

Genprex, Inc.

stock price on the chart and check out the list of the most volatile stocks — is

Genprex, Inc.

there?

Today

Genprex, Inc.

has the market capitalization of

‪4.13 M‬

, it has increased by

3.23

% over the last week.

Yes, you can track

Genprex, Inc. financials

in yearly and quarterly reports right on TradingView.

Genprex, Inc.

is going to release the next earnings report on

Aug 28, 2024

. Keep track of upcoming events with our Earnings Calendar.

GNPX

earnings for the last quarter are

−3.69

USD

per share, whereas the estimation was

−3.69

USD

resulting in a

% surprise. The estimated earnings for the next quarter are

−2.30

USD

per share. See more details about

Genprex, Inc. earnings

.

Genprex, Inc. revenue

for the last quarter amounts to

USD

, matching the estimated figure, and no changes in revenue are expected for the next quarter.

GNPX

net income for the last quarter is

‪−5.97 M‬

USD

, while the quarter before that showed

‪−5.93 M‬

USD

of net income which accounts for

−0.67

% change. Track more

Genprex, Inc. financial stats

to get the full picture.

No,

GNPX

doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of

Jul 24, 2024

, the company has

26.00

employees. See our rating of the largest employees — is

Genprex, Inc.

on this list?

Like other stocks,

GNPX

shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade

Genprex, Inc.

stock right from TradingView charts — choose your broker and connect to your account.

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So

Genprex, Inc.

technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating

Genprex, Inc.

stock shows the sell signal. See more of

Genprex, Inc. technicals

for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

GNPX Stock Price and Chart — NASDAQ:GNPX — TradingView (2024)

FAQs

What is the price prediction for Genprex? ›

The average one-year price target for Genprex, Inc. is $168.30. The forecasts range from a low of $10.10 to a high of $336.00. A stock's price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings.

Is GNPx a good stock to buy? ›

Based on 1 Wall Street analysts who have issued ratings for Genprex in the last 12 months, the stock has a consensus rating of "Buy." Out of the 1 analysts, 1 has given a buy rating for GNPX.

What is NASDAQ-100 on Tradingview? ›

The NASDAQ-100 is an index that is constituted by 100 of the largest companies listed on the NASDAQ stock exchange, which is the second largest in the world only after the New York Stock Exchange by market capitalization.

What is the stock forecast for GNPX in 2030? ›

Genprex Stock Prediction 2030

In 2030, the Genprex stock will reach $ 255.08 if it maintains its current 10-year average growth rate. If this Genprex stock prediction for 2030 materializes, GNPX stock will grow 12,718.02% from its current price.

What is the price prediction for ADTX 2025? ›

$62.22 ↑2,665.21% Estimated share price by May 22, 2025.

Which indicator is best for Nasdaq 100? ›

Relative Strength Index (RSI)

The RSI is a momentum oscillator that measures the speed and change of price movements. Scalpers may use the RSI to identify potential overbought or oversold conditions, which may indicate a reversal in the price trend.

What is the Nasdaq 100 strategy? ›

The strategy uses a mean reversion component to penalize stocks that rise too much or too fast. Protection - The strategy allocates a portion to treasuries to balance out the supercharged Nasdaq momentum stocks. This improves risk adjusted returns and moderates strategy drawdowns.

Why do traders use TradingView? ›

TradingView is an ideal platform for analysing market data and helping traders to weigh up the pros and cons of buying or selling an asset.

What is the price prediction for bancor in 2030? ›

Bancor (BNT) Price Prediction 2030
YearPrice
2025$ 0.666853
2026$ 0.700196
2027$ 0.735206
2030$ 0.851093
1 more row

What is the stock price prediction for WBX in 2025? ›

Wallbox N.V. stock prediction for 1 year from now: $ 21.75 (1,399.95%) Wallbox N.V. stock forecast for 2025: $ 1.195084 (-17.58%) Wallbox N.V. stock prediction for 2030: $ 0.454518 (-68.65%)

What is the stock price forecast for Gehc in 2025? ›

GE HealthCare Technologies Inc. stock prediction for 1 year from now: $ 67.09 (-17.41%) GE HealthCare Technologies Inc. stock forecast for 2025: $ 88.32 (8.73%) GE HealthCare Technologies Inc. stock prediction for 2030: $ 134.25 (65.27%)

What is the stock price forecast for Regeneron in 2030? ›

According to our Regeneron Pharmaceuticals stock prediction for 2030, REGN stock will be priced at $ 2,274.08 in 2030. This forecast is based on the stock's average growth over the past 10 years.

Top Articles
The Best Health And Fitness Apps
Mike Li on LinkedIn: On this day every year, I’m reminded of my roots. I joined the Air Force… | 14 comments
It’s Time to Answer Your Questions About Super Bowl LVII (Published 2023)
Kreme Delite Menu
Jackerman Mothers Warmth Part 3
Brady Hughes Justified
Gomoviesmalayalam
12 Rue Gotlib 21St Arrondissem*nt
How Many Cc's Is A 96 Cubic Inch Engine
Western Union Mexico Rate
Health Benefits of Guava
Koordinaten w43/b14 mit Umrechner in alle Koordinatensysteme
Guardians Of The Galaxy Showtimes Near Athol Cinemas 8
Coffman Memorial Union | U of M Bookstores
What's Wrong with the Chevrolet Tahoe?
Aquatic Pets And Reptiles Photos
Wunderground Huntington Beach
Craigslist Pets Sac
Missed Connections Dayton Ohio
Log in or sign up to view
Diamond Piers Menards
Free Online Games on CrazyGames | Play Now!
Trivago Sf
Weepinbell Gen 3 Learnset
Long Island Jobs Craigslist
Rimworld Prison Break
Parc Soleil Drowning
Play It Again Sports Norman Photos
1 Filmy4Wap In
4 Times Rihanna Showed Solidarity for Social Movements Around the World
City Of Durham Recycling Schedule
Gillette Craigslist
Sams Gas Price Sanford Fl
27 Fantastic Things to do in Lynchburg, Virginia - Happy To Be Virginia
Xxn Abbreviation List 2023
Orange Park Dog Racing Results
Weather Underground Durham
Duke University Transcript Request
Ice Dodo Unblocked 76
Account Now Login In
R/Sandiego
Yoshidakins
Aliciabibs
Updates on removal of DePaul encampment | Press Releases | News | Newsroom
Luvsquad-Links
Citroen | Skąd pobrać program do lexia diagbox?
National Weather Service Richmond Va
My Eschedule Greatpeople Me
877-552-2666
Gummy Bear Hoco Proposal
How to Choose Where to Study Abroad
Latest Posts
Article information

Author: Chrissy Homenick

Last Updated:

Views: 5333

Rating: 4.3 / 5 (54 voted)

Reviews: 85% of readers found this page helpful

Author information

Name: Chrissy Homenick

Birthday: 2001-10-22

Address: 611 Kuhn Oval, Feltonbury, NY 02783-3818

Phone: +96619177651654

Job: Mining Representative

Hobby: amateur radio, Sculling, Knife making, Gardening, Watching movies, Gunsmithing, Video gaming

Introduction: My name is Chrissy Homenick, I am a tender, funny, determined, tender, glorious, fancy, enthusiastic person who loves writing and wants to share my knowledge and understanding with you.